BORGHETTI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 2.402
EU - Europa 1.007
AS - Asia 437
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
OC - Oceania 2
Totale 3.867
Nazione #
US - Stati Uniti d'America 2.396
IT - Italia 269
CN - Cina 233
UA - Ucraina 174
DE - Germania 161
PL - Polonia 125
HK - Hong Kong 89
FI - Finlandia 87
SG - Singapore 54
IE - Irlanda 50
GB - Regno Unito 41
FR - Francia 35
VN - Vietnam 24
CZ - Repubblica Ceca 19
RU - Federazione Russa 11
TR - Turchia 11
IN - India 10
NL - Olanda 7
SE - Svezia 7
CA - Canada 6
EU - Europa 6
MK - Macedonia 4
UG - Uganda 4
BD - Bangladesh 3
BE - Belgio 3
BR - Brasile 3
ID - Indonesia 3
JP - Giappone 3
AU - Australia 2
BY - Bielorussia 2
HU - Ungheria 2
PE - Perù 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 3.867
Città #
Fairfield 315
Ashburn 276
Chandler 198
Woodbridge 180
Houston 167
Seattle 155
Jacksonville 136
Cambridge 125
Warsaw 124
Wilmington 113
Dearborn 93
New York 92
Hong Kong 87
Princeton 84
Helsinki 79
Ann Arbor 63
Brescia 47
Dublin 47
Beijing 44
Nanjing 39
Milan 32
Shanghai 32
Singapore 32
Dong Ket 24
Los Angeles 24
San Diego 24
Washington 21
Boardman 18
Des Moines 17
Brno 16
Nanchang 15
Changsha 12
Munich 12
Hebei 11
Shenyang 11
Jinan 10
London 10
Kunming 9
Rome 7
Lancaster 6
Toronto 6
Zhengzhou 6
Haikou 5
Jiaxing 5
Kocaeli 5
Ningbo 5
Tianjin 5
Verona 5
Bergamo 4
Ceto 4
Chiswick 4
Falls Church 4
Hanover 4
Mountain View 4
San Francisco 4
Taizhou 4
Bologna 3
Buccinasco 3
Dhaka 3
Florence 3
Hangzhou 3
Hefei 3
Monza 3
Orange 3
Parma 3
Pune 3
Redwood City 3
Rozzano 3
Siena 3
Tokyo 3
Turin 3
Amsterdam 2
Brussels 2
Chicago 2
Chongqing 2
Civitanova Marche 2
Como 2
Cremona 2
Cuggiono 2
Dallas 2
Deiva Marina 2
Falkenstein 2
Hounslow 2
Iseo 2
Lima 2
L’Aquila 2
Minsk 2
Norwalk 2
Nürnberg 2
Osimo 2
Paris 2
Pontedera 2
Redmond 2
Strasbourg 2
Sydney 2
Abidjan 1
Acton 1
Adana 1
Albiolo 1
Almere Stad 1
Totale 2.979
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 186
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 178
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 156
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 153
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 152
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 144
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 136
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 127
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 126
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 119
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 119
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 118
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 115
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 113
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 108
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 108
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 107
From Molecular to Clinical Radiation Biology of Glioblastoma 106
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 104
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 103
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 96
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 87
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 84
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 78
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 75
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 70
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 69
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 69
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 66
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 62
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 57
Current radiotherapy techniques in NSCLC: challenges and potential solutions 56
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 49
Letter to the Editor 46
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 44
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 42
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 41
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 38
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 30
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 30
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 29
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 27
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer 26
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 23
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 18
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 16
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 15
null 13
Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the 'radio talk' webinars 12
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 11
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience 10
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 9
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 8
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 4
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 4
Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer 3
Totale 3.995
Categoria #
all - tutte 21.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020839 0 34 36 78 59 146 123 105 76 87 40 55
2020/2021755 27 81 42 66 36 82 48 73 72 106 60 62
2021/2022437 35 38 10 13 27 31 26 34 27 47 24 125
2022/2023514 55 18 24 36 51 105 5 69 96 6 31 18
2023/2024775 29 16 94 45 45 179 35 47 102 41 36 106
2024/202553 28 25 0 0 0 0 0 0 0 0 0 0
Totale 3.995